CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Operating expenses:
Research and development	$ (198)	$ 93	$ (324)	$ (140)
Selling and marketing	0	0	0	0
General and administrative	(43)	(146)	(132)	(305)
Operating loss	(241)	(53)	(456)	(445)
Financial income (expenses), net	(2,548)	(947)	(2,345)	(871)
Net loss	(2,789)	(1,000)	(2,801)	(1,316)
Non-controlling interests	(95)	(4)	(177)	(134)
Net loss attributable to equity holders of the Company	$ (2,694)	$ (996)	$ (2,624)	$ (1,182)
Basic net loss per share	$ (0.66)	$ (0.24)	$ (0.66)	$ (0.31)
Diluted net loss per share	$ (0.66)	$ (0.24)	$ (0.66)	$ (0.31)
Weighted average number of Ordinary shares used in computing basic loss per share	4,215,571	4,215,571	4,215,571	4,215,571
Weighted average number of Ordinary shares used in computing diluted loss per share	4,215,571	4,215,571	4,215,571	4,215,571